Is DOTS-plus a feasible and cost-effective strategy?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16968122.
- Also identified by PMC identifier 1564173.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines.
Medical subject headings
- Directly Observed Therapy
- Tuberculosis, Multidrug-Resistant